Venn Life Sciences, the consultancy services division of Hvivo, has secured a two-year contract with a pharmaceutical client worth €3.2m.
A consultancy team based in the Netherlands will provide drug test consultancy and programming services to this global client on a number of drug development programmes.
Venn will help this client study the absorption, distribution and excretion of their drugs within the body. Studying a drug’s journey through the body is known as pharmacokinetics (PK)
hVIVO plc (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and antivirals using human challenge clinical trials, providing end-to-end early clinical development services for its broad and long-standing client base of biopharma companies.